Stocksigma LogoStocksigma Logo

Modern Diagnostic Reports Q2FY27 IPO Proceeds Utilization; Notes Capex Delays

CARE Ratings' Monitoring Agency Report for Modern Diagnostic & Research Centre shows Rs.32.46 crore of its Rs.36.89 crore IPO proceeds utilized through

Modern Diagnostic Reports Q2FY27 IPO Proceeds Utilization; Notes Capex Delays

Modern Diagnostic & Research Centre Ltd 路 Others (Uncategorized) 路 17 Nov 2026, 4:57 pm

Modern Diagnostic Reports Q2FY27 IPO Proceeds Utilization; Notes Capex Delays CARE Ratings' Monitoring Agency Report for Modern Diagnostic & Research Centre shows Rs.32.46 crore of its Rs.36.89 crore IPO proceeds utilized through 30th Sep'26, leaving Rs.4.43 crore unutilized. Capex deployment faced delays against original prospectus timelines, with Rs.16.33 crore spent out of the allocated Rs.20.69 crore. The remaining capex of Rs.4.36 crore will spill into subsequent financial years following board approval on 13th May'26. Additionally, the company's stock price has declined approximately 36.67% from its issue price as of 4th Nov'26.

Original exchange filing (PDF)

More announcements from Modern Diagnostic & Research Centre Ltd

All Modern Diagnostic & Research Centre Ltd announcements